Cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to ...

Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Drs. Fatemeh Ardeshir-Larijani and Mohamed Abazeed discuss a validated AI model that can predict how patients with advanced ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine say they have shed new light on the location and function of ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

Cancer does not develop overnight. It can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that could pave the way for a new generation of immunotherapies. Cancer ...

Pathologists' examinations of tissue samples from skin cancer tumors improved when they were assisted by an AI tool. The ...